tiprankstipranks
Relmada Therapeutics (RLMD)
NASDAQ:RLMD

Relmada Therapeutics (RLMD) Cash flow

264 Followers

Relmada Therapeutics Cash Flow

RLMD's free cash flow for Q3 2023 was $-11.63M. For the 2023 fiscal year, RLMD's free cash flow was decreased by $-11.93M and operating cash flow was $-11.63M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Jun 19Jun 18
Operating Cash Flow
$ -90.88M$ -103.80M$ -91.87M$ -27.81M$ -10.50M$ -6.00M
Investing Cash Flow
$ 73.77M$ 19.73M$ -54.12M$ -34.45M$ 0.00$ -12.39K
Financing Cash Flow
$ 978.98K$ 45.02M$ 187.94M$ 28.47M$ 17.48M$ 6.54M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 83.51M$ 5.40M$ 44.44M$ 2.50M$ 9.22M$ 2.24M
Income Tax Paid Supplemental Data
---$ 0.00$ 0.00$ 0.00
Interest Paid Supplemental Data
---$ 2.42K$ 5.93K$ 2.56K
Issuance Of Capital Stock
$ 286.18K$ 42.73M$ 184.64M$ 20.53M$ 17.76M$ 0.00
Issuance Of Debt
-$ -50.00K--$ 0.00$ 6.53M
Repayment Of Debt
-$ -50.00K-$ -110.25K$ -285.17K-
Free Cash Flow
$ -90.88M$ -103.80M$ -91.87M$ -27.81M$ -10.50M$ -6.01M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Relmada Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis